Effects of Th2 pulmonary inflammation in mice with bleomycin-induced pulmonary fibrosis

Respirology

Volumn 13, Issue 6, 2008, Pages 788-798

  Hirata, Hirokuni ^a   Arima, Masafumi ^a,b   Fukushima, Yasutsugu ^a   Ishii, Yoshiki ^a   Tokuhisa, Takeshi ^b   Fukuda, Takeshi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bcl6 transgenic mice; Bleomycin; Eosinophil; Pulmonary fibrosi

Indexed keywords

BLEOMYCIN; COLLAGEN; MESSENGER RNA; OVALBUMIN; PROTEIN BCL 6; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INSTILLATION; EOSINOPHIL; HISTOPATHOLOGY; LUNG FIBROSIS; LUNG LAVAGE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; REPRESSOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; DNA; MICE; MICE, TRANSGENIC; OVALBUMIN; PROTO-ONCOGENE PROTEINS C-BCL-6; PULMONARY FIBROSIS; TH2 CELLS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 51349096042     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01361.x     Document Type: Article

References (53)

1. Flaherty KR, Colby TV, Travis WD, Toews GB, Mumford J et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am. J. Respir. Crit. Care Med. 2003 169 : 1410 15.
2. Desai SR, Veeraraghavan S, Hansell DM, Nikolakopolou A, Goh NS et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004 232 : 560 7.
3. Kaneoka H, Sasatomi Y, Miyagi K, Kiyoshi Y, Takeda S et al. A rare case of dermatomyositis associated with immune-complex type glomerulonephritis, idiopathic thrombopenic purpura, pulmonary fibrosis and lung cancer. Clin. Exp. Rheumatol. 2003 21 : 801 2.
4. Franceschini F, Cavazzana I, Generali D, Quinzanini M, Viardi L et al. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients. J. Rheumatol. 2002 29 : 1393 7.
5. Pilewski JM, Liu L, Henry AC, Knauer AV, Feghali-Bostwick CA. Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am. J. Pathol. 2005 166 : 399 407.
6. Pignatti P, Brunetti G, Moretto D, Yacoub MR, Fiori M et al. Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2006 173 : 310 17.
7. Huaux F, Lardot C, Arras M, Delos M, Many MC et al. Lung fibrosis induced by silica particles in NMRI mice is associated with an upregulation of the p40 subunit of interleukin-12 and Th-2 manifestations. Am. J. Respir. Crit. Care Med. 1999 20 : 561 72.
8. Ishii Y, Fujimoto S, Fukuda T. Gefitinib prevents bleomycin-induced lung fibrosis in mice. Am. J. Respir. Crit. Care Med. 2006 174 : 550 6.
9. Chandler DB, Hyde DM, Giri SN. Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. Am. J. Pathol. 1983 112 : 170 7.
10. Hu B, Ullenbruch MR, Jin H, Gharaee-Kermani M, Phan SH. An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 2007 211 : 455 62.
11. Yoshida M, Taguchi O, Gabazza EC, Yasui H, Kobayashi T et al. The effect of low-dose inhalation of nitric oxide in patients with pulmonary fibrosis. Eur. Respir. J. 1997 10 : 2051 4.
12. Wang XM, Zhang Y, Kim HP, Zhou Z, Feqhali-Bostwick CA et al. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J. Exp. Med. 2006 203 : 2895 906.
13. Liu T, Jin H, Ullenbruch M, Hu B, Hashimoto N et al. Regulation of found in inflammatory zone 1 expression in bleomycin-induced lung fibrosis: role of IL-4/IL-13 and mediation via STAT-6. J. Immunol. 2004 173 : 3425 31.
14. Bakshi CS, Malik M, Carrico PM, Sellati TJ. T-bet deficiency facilitates airway colonization by Mycoplasma pulmonis in a murine model of asthma. J. Immunol. 2006 177 : 1786 95.
15. Gharaee-Kermani M, Nozaki Y, Hatano K, Phan SH. Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis. Cytokine 2001 15 : 138 47.
16. Ando M, Miyazaki E, Fukami T, Kumamoto T, Tsuda T. Interleukin-4- producing cells in idiopathic pulmonary fibrosis: an immunohistochemical study. Respirology 1999 4 : 383 91.
17. Wallace WA, Ramage EA, Lamb D, Howie SE. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin. Exp. Immunol. 1995 101 : 436 41.
18. Huaux F, Liu T, McGarry B, Ullenbruch M, Phan SH. Dual roles of IL-4 in lung injury and fibrosis. J. Immunol. 2003 170 : 2083 92.
19. Jakubzick C, Choi ES, Joshi BH, Keane MP, Kunkel SL et al. Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells. J. Immunol. 2003 171 : 2684 93.
20. Ye BH, Lista F, Lo Coco F, Knowles DM, Offit K et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 1993 262 : 747 50.
21. Kusam S, Toney LM, Sato H, Dent AL. Inhibition of Th2 differentiation and GATA-3 expression by BCL-6. J. Immunol. 2003 170 : 2435 41.
22. Arima M, Toyama H, Ichii H, Kojima S, Okada S et al. A putative silencer element in the IL-5 gene recognized by Bcl6. J. Immunol. 2002 169 : 829 36.
23. Takeda N, Arima M, Tsuruoka N, Okada S, Hatano M et al. Bcl6 is a transcriptional repressor for the IL-18 gene. J. Immunol. 2003 171 : 426 31.
24. Tokuda A, Itakura M, Onai N, Kimura H, Kuriyama T et al. Pivotal role of CCR1-positive leukocytes in bleomycin-induced lung fibrosis in mice. J. Immunol. 2000 164 : 2745 51.
25. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 1988 41 : 467 70.
26. Tabata C, Tabata R, Kadokawa Y, Hisamori S, Takahashi M et al. Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice. J. Immunol. 2007 179 : 708 14.
27. Nakao A, Miike S, Hatano M, Okamura K, Tokuhisa T et al. Blockade of transforming growth factor beta/Smad signaling in T cells by overexpression of Smad7 enhances antigen-induced airway inflammation and airway reactivity. J. Exp. Med. 2000 192 : 151 8.
28. Bitterman PB, Adelberg S, Crystal RG. Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders. J. Clin. Invest. 1983 72 : 1801 13.
29. Homma S, Nagaoka I, Abe H, Takahashi K, Seyama K et al. Localization of platelet-derived growth factor and insulin-like growth factor I in the fibrotic lung. Am. J. Respir. Crit. Care Med. 1995 152 : 2084 9.
30. Rom WN, Basset P, Fells GA, Nukiwa T, Trapnell BC et al. Alveolar macrophages release an insulin-like growth factor I-type molecule. J. Clin. Invest. 1988 82 : 1685 93.
31. Martinet Y, Rom WN, Grotendorst GR, Martin GR, Crystal RG. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 1987 317 : 202 9.
32. Khalil N, O'Connor RN, Unruh HW, Warren PW, Flanders KC et al. Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 1991 5 : 155 62.
33. Gillery P, Leperre A, Maquart FX, Borel JP. Insulin-like growth factor-I (IGF-I) stimulates protein synthesis and collagen gene expression in monolayer and lattice cultures of fibroblasts. J. Cell. Physiol. 1992 152 : 389 96.
34. Goldstein RH, Poliks CF, Pilch PF, Smith BD, Fine A. Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts. Endocrinology 1989 124 : 964 70.
35. Krupsky M, Fine A, Kuang PP, Berk JL, Goldstein RH. Regulation of type I collagen production by insulin and transforming growth factor-β in human lung fibroblasts. Connect. Tissue Res. 1996 34 : 53 62.
36. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999 96 : 857 68.
37. Kulik G, Weber MJ. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Mol. Cell Biol. 1998 18 : 6711 18.
38. Linseman DA, Phelps RA, Bouchard RJ, Le SS, Laessig TA et al. Insulin-like growth factor-I blocks Bcl-2 interacting mediator of cell death (Bim) induction and intrinsic death signaling in cerebellar granule neurons. J. Neurosci. 2002 22 : 9287 97.
39. Zhang HY, Phan SH. Inhibition of myofibroblast apoptosis by transforming growth factor β(1). Am. J. Respir. Cell Mol. Biol. 1999 21 : 658 65.
40. Bonner JC, Osornio-Vargas AR, Badgett A, Brody AR. Differential proliferation of rat lung fibroblasts induced by the platelet-derived growth factor-AA, -AB, and -BB isoforms secreted by rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 1991 5 : 539 47.
41. Henke C, Marineili W, Jessurun J, Fox J, Harms D et al. Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury. Am. J. Pathol. 1993 143 : 1189 99.
42. Thrall RS, Lovett EJ, Barton RW, McCormick JR, Phan SH et al. The effect of T cell depletion on the development of bleomycin induced pulmonary fibrosis in the rat. Am. Rev. Respir. Dis. 1980 121 : A99.
43. Lake-Bullock MHV, Zhu J, Hao H, Cohen DA, Kaplan AM. T cell independence of bleomycin-induced pulmonary fibrosis. J. Leukoc. Biol. 1999 65 : 187 95.
44. Lee CG, Cho SJ, Kang MJ, Chapoval SP, Lee PJ et al. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J. Exp. Med. 2004 200 : 377 89.
45. El-Karef A, Yoshida T, Gabazza EC, Nishioka T, Inada H et al. Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. J. Pathol. 2007 211 : 86 94.
46. Allen JT, Knight RA, Bloor CA, Spiteri MA. Enhanced insulin-like growth factor binding protein-related protein 2 (connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am. J. Respir. Cell Mol. Biol. 1999 21 : 693 700.
47. Suzuma K, Naruse K, Suzuma I, Takahara N, Ueki K et al. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J. Biol. Chem. 2000 275 : 40725 31.
48. Kaviratne M, Hesse M, Leusink M, Cheever AW, Stephen J et al. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-β independent. J. Immunol. 2004 173 : 4020 9.
49. Hernandez HJ, Rutitzky LI, Lebens M, Holmgren J, Stadecker MJ. Diminished immunopathology in Schistosoma mansoni infection following intranasal administration of cholera toxin B-immunodominant peptide conjugate correlates with enhanced transforming growth factor-β production by CD4 T cells. Parasite Immunol. 2002 24 : 423 7.
50. Kanzler S, Lohse AW, Keil A, Henninger J, Dienes HP et al. TGF-β1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am. J. Physiol. 1999 276 : G1059 68.
51. Dooley S, Delvoux B, Streckert M, Bonzel L, Stopa M et al. 2001. Transforming growth factor β signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts: TGF β signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett. 2001 502 : 4 10.
52. Chapman HA. Disorders of lung matrix remodeling. J. Clin. Invest. 2004 113 : 148 7.
53. Chen ES, Greenlee BM, Wills-Karp M, Moller DR. Attenuation of lung inflammation and fibrosis in interferon-γ-deficient mice after intratracheal bleomycin. Am. J. Respir. Cell Mol. Biol. 2001 24 : 545 55.